The analysis was further extended to compare T cells at week 1 and 4 of tumor growth i.e., before and after TLT-1/vehicle injections in mice, which further confirmed the decrease in effector (IFNγ-producing) CD8 T cells in TLT-1–injected mice (Fig. S2 G). This evidence concerns the gene CD8A and neoplasm.